Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. - Wikidata - awgldk - TriplyDB

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

http://www.wikidata.org/entity/Q36119996

about

How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals?Gut microbiome and anticancer immune response: really hot Sh*t!A physicians' wish list for the clinical application of intestinal metagenomics.The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications.Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Gut microbiota modulation of chemotherapy efficacy and toxicity.Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia.Dissecting Target Toxic Tissue and Tissue Specific Responses of Irinotecan in Rats Using Metabolomics Approach.Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.Interaction between host cells and microbes in chemotherapy-induced mucositis.Microbiota: a key orchestrator of cancer therapy.Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats.5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition in vitro.Human Gut Microbiota and Gastrointestinal Cancer.From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation.Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon.β-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut The implementation of omics technologies in cancer microbiome research

P2860

Q26771113-B3481F72-FE37-4B0D-966C-D9751D267701 Q28538671-992385A7-A0DD-431A-B800-93153A1E9A20 Q33728328-15B768D8-0345-44E4-B5F8-7A4951C06C23 Q34924272-10C33C81-4208-42B6-93F5-5C437AED5054 Q35148869-0E36D006-D171-4A4B-8C5A-730A6F66C325 Q35152783-D4FE60EB-49BA-4191-AA09-BDA6EB004AD2 Q35209399-C599C24A-A7B5-48FD-B710-FC8875284AE3 Q36171894-8F4DC282-CF37-4FDD-AC18-20287994F7A1 Q36300217-4823C3DF-2068-407E-BEB7-45524FE76EB9 Q37268163-71CCD92D-D054-48B5-AC41-EB18E09932D3 Q37692023-F505169C-1129-4130-B8BD-5D3CF2312AE6 Q37731433-F9D2F2E5-38E2-4B0B-8EC7-5E2C03C190A7 Q38102867-70455CCC-8492-4214-919E-4E82861A0D45 Q39183428-28F7AE96-0887-488E-9DBA-ADB54E5FA3D0 Q41160069-67892815-2A64-447E-B062-1A954B9BD9AA Q46257516-22202EE1-8E5D-419B-AF18-AFBCE195F082 Q52374120-B2238050-FFFB-4C2A-9AD5-439115C19A13 Q55001002-5671A651-3D77-48A7-A1AA-E481D6C896CF Q55040688-496C81F7-591D-4FF9-99C1-CF36571C9B4E Q55198257-675E5246-D728-4400-9379-46EBF7EB2E33 Q58608842-6E94ED9D-B587-4382-A50A-80498A7721BB Q58762649-614396BC-DE82-413C-80F8-351082E698D8

P2860

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

http://www.wikidata.org/entity/Q36119996

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

@ast

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

@en

type

label

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

@ast

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

@en

prefLabel

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

@ast

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

@en

P1433

Q36119996-FFA271DD-E959-4BCB-BF68-A7B6CC7F6080

P1476

Q36119996-D16089E1-E5EC-40AD-853D-E7AB83186D74

P2093

Q36119996-207A3B23-350B-4B88-9093-7C31D2EB30E1

Q36119996-20A640A5-DB57-4B4C-B832-1BB1A94C9014

Q36119996-49E2EECE-11FF-4452-9DB8-F38DD1A1DB32

Q36119996-AE62075F-AC10-4CBF-B147-9C99E1ACB436

Q36119996-B6A96F7E-EDE2-4AA1-A80D-4C5D0D1A9AD0

Q36119996-DBC23FCA-3E8D-4BD2-AD3A-19B3D5C0C1A1

P2860

Q36119996-03F4F8BE-6CBC-4D46-9118-3539825A74F3

Q36119996-0DB05640-AE42-49BE-8ED9-4E9EC669C0EC

Q36119996-0FF5A234-6A7B-411B-87BA-1786D2BB4392

Q36119996-1A67C76F-31BD-4AEE-A93A-5481A1F67240

Q36119996-1AF0CA48-6707-484F-9B26-E6B5DD479515

Q36119996-233F09E7-3AE3-43CA-808E-C837D1EE1915

Q36119996-26FADEC0-F4A3-4081-A67C-D3BAFDB46EEE

Q36119996-2A86D03C-A11C-4F5C-9F4A-67888B25E708

Q36119996-38430D3D-7746-4996-ADA7-1D2C15657F70

Q36119996-3A71B566-F747-418E-ADB3-F3D879E2DF86

P304

Q36119996-74104F16-930C-434D-8577-A7B5C688DB2E

P31

Q36119996-F990C33B-461F-4655-8FD4-38B497EED878

P356

Q36119996-5A6D876B-DF05-402A-9C66-A0F6A31EA943

P407

Q36119996-D7AADCFD-B8E2-419A-947D-74553A19C53F

P433

Q36119996-F695135B-7168-4A0D-AB0C-E9EA80FA3C39

P478

Q36119996-DDB1B007-212D-424F-95CC-29A1FFC1AEF1

P50

Q36119996-26B30C8F-BAEA-4E6D-9170-B06C5E70FF01

Q36119996-5C7A5580-FF8A-4FD1-9984-9FA473059255

Q36119996-6BF9487C-67C4-4D6F-8760-9AD183A6ACD7

P577

Q36119996-7E28E565-DC56-4488-AE1F-D4155624F065

P5875

Q36119996-ED474862-23E6-40E1-83B5-53BAB02B3807

P698

Q36119996-BF2F712F-F135-4CD2-B843-2839EE306DBC

P921

Q36119996-AEC18E49-3E17-4A49-8600-38E1766D2960

P932

Q36119996-197A0E74-ABFD-4108-A828-1B4C98546A29

P356

JOURNAL.PONE.0039764

P1433

P1476

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.

@en

P2093

Ali Ketabi

http://www.w3.org/2001/XMLSchema#string

Hongyu Xue

http://www.w3.org/2001/XMLSchema#string

Ilona Bibova

http://www.w3.org/2001/XMLSchema#string

Levinus A Dieleman

http://www.w3.org/2001/XMLSchema#string

Michael B Sawyer

http://www.w3.org/2001/XMLSchema#string

Xiaoxi B Lin

http://www.w3.org/2001/XMLSchema#string

P2860

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer's patches in endotoxemic mice

Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond.

The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.

Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes.

Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20.

Nonstarch polysaccharides modulate bacterial microbiota, pathways for butyrate production, and abundance of pathogenic Escherichia coli in the pig gastrointestinal tract

Bacteria as trigger for chronic gastrointestinal disorders.

Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers.

Immune responses to the microbiota at the intestinal mucosal surface.

P304

e39764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0039764

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Michael G. Gänzle

Catherine J. Field

Vickie E. Baracos

P577

2012-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230586724

http://www.w3.org/2001/XMLSchema#string

P698

22844397

http://www.w3.org/2001/XMLSchema#string

P921

P932

3406026

http://www.w3.org/2001/XMLSchema#string